Jane Street
HRTX icon

Jane Street’s Heron Therapeutics HRTX Stock Holding History

Jane Street’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,200
Closed -$25K – 12216
2026
Q1 		$25K Buy
31,200
+14,600
+88% +$16.9K ﹤0.01% 11153
2025
Q4 		$21.6K Sell
16,600
-3,500
-17% -$4.32K ﹤0.01% 10710
2025
Q3 		$25.3K Buy
+20,100
New +$31.9K ﹤0.01% 10492
2025
Q2 		– Sell
-413,800
Closed -$910K – 10153
2025
Q1 		$910K Buy
+413,800
New +$803K ﹤0.01% 5746
2024
Q2 		– Sell
-494,800
Closed -$1.37M – 9724
2024
Q1 		$1.37M Buy
+494,800
New +$1.24M ﹤0.01% 4823
2022
Q4 		– Sell
-12,100
Closed -$51K – 9532
2022
Q3 		$51K Buy
+12,100
New +$47.3K ﹤0.01% 8918
2022
Q2 		– Sell
-13,600
Closed -$78K – 10132
2022
Q1 		$78K Sell
13,600
-14,500
-52% -$106K ﹤0.01% 9544
2021
Q4 		$257K Sell
28,100
-37,900
-57% -$387K ﹤0.01% 8441
2021
Q3 		$706K Sell
66,000
-88,800
-57% -$1.08M ﹤0.01% 6627
2021
Q2 		$2.4M Buy
154,800
+131,500
+564% +$2.09M ﹤0.01% 3977
2021
Q1 		$378K Buy
23,300
+11,500
+97% +$205K ﹤0.01% 7313
2020
Q4 		$250K Buy
+11,800
New +$205K ﹤0.01% 6665
2020
Q3 		– Sell
-46,400
Closed -$683K – 7463
2020
Q2 		$683K Buy
+46,400
New +$762K ﹤0.01% 4612
2018
Q3 		– Sell
-22,100
Closed -$859K – 5358
2018
Q2 		$859K Buy
+22,100
New +$704K ﹤0.01% 2941

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Jane Street's HRTX Position: Q2 2026 in Review

Jane Street opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 25,672 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #11295 among its holdings. This is a return to the name: Jane Street previously reported a position in HRTX as recently as Q4 2025.

Jane Street first reported a position in HRTX in Q1 2014 and has held it in 36 quarters since. The position peaked at $1.78M in Q4 2025. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Jane Street held 25,672 shares of Heron Therapeutics worth $11K as of Q2 2026.
  • Heron Therapeutics was a new Jane Street position in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11295 holding.
  • Jane Street first reported a position in Heron Therapeutics in Q1 2014 and has held it in 36 quarters since.
  • Jane Street's Heron Therapeutics position peaked at $1.78M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.